List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 4 January 2024

Current Report No. 2/2024

Date of preparation: 11 January 2024

Subject: List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 4 January 2024

The Management Board of Captor Therapeutics S.A. with its registered office in Wroclaw (the “Company”) provides the list of shareholders of the Company holding at least 5% of votes at the Extraordinary General Meeting (the “EOGM”) of the Company which was held on 4 January 2024:

1. Michał Walczak holding 1,471,145 votes at the EOGM, constituting 40.44% of votes at the EOGM and 25.39% of the total number of votes;

2. Paweł Holstinghausen Holsten holding 950,041 votes at the EOGM, constituting 26.12% of votes at the EOGM and 16.40% of the total number of votes;

3. Sylvain Cottens holding 526,730 votes at the EOGM, constituting 14.48% of votes at the EOGM and 9.09% of the total number of votes;

4. Nationale-Nederlanden Otwarty Fundusz Emerytalny holding 340,662 votes at the EOGM, constituting 9.36% of votes at the EOGM and 5.88% of the total number of votes;

5. funds managed by Powszechne Towarzystwo Emerytalne Allianz Polska S.A. (Allianz Polska Otwarty Fundusz Emerytalny and Allianz Polska Dobrowolny Fundusz Emerytalny) holding 230,150 votes at the EOGM, constituting 6.33% of votes at the EOGM and 3.97% of the total number of votes.